Friday December 05 2008 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
  • A-Z

Genetix Fully automatable Petri Dish is first of a new line

New Milton, Hampshire, UK, 14 April, 2005 - Genetix has announced the launch of the unique PetriWell plate which, for the first time, allows complete handling of a Petri dish by robotic processes.

Comprising a Petri dish held within an SBS compliant plate framework, the plate can be used in a wide range of applications, including cell culture work-up.

Made from a material known as EquiGlass, the plate guarantees the high degree of flatness and optical clarity essential where imaging of cell growth is required. A growth area of 40cm2 facilitates productive cell growth. The black upper structure serves to minimise extraneous light whilst improved cell adhesion is achieved through a novel surface treatment. The plates are also available untreated.

Genetix plans to add to the range by introducing plates in 6, 24, 96 and 384-well formats.

For further information on the PetriWell plates please contact Genetix by email at: info@genetix.com or telephone +44-1425-624600

Text ends 

 

About Genetix

Genetix Limited provides automated systems for cell biology, and proteomic and genomic research. It supplies many leading academic institutions world-wide and major international companies involved in the drug discovery process including GSK, AstraZeneca and Novartis.  

Genetix made a significant contribution to the Human Genome Project by supplying high-throughput equipment to seven of the leading eight laboratories of the consortium. Genetix, through its R&D expertise and scientific resource, is committed to the continual development of innovative solutions to accelerate the rate of global scientific discovery.  

Genetix is quoted on the London Stock Exchange (symbol GTX) and is based in New Milton, Hampshire, UK.   

www.genetix.com 

Enquiries:            

Genetix Ltd                                                 

Andrew Maxwell, Business Manager             

Tel: +44 (0)1425 624 600                              

Email: andrew.maxwell@genetix.com           

Media enquiries:

Kapler Communications Ltd

Richard Kent, Director

Tel: +44 (0) 1480 471 117

richard@kapleronline.com


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright © 1997-2008 - BioPortfolio Limited.